TRACON Pharmaceuticals Inc Call to Discuss Collaborative Partnership Agreement with 3D Medicines (Beijing) Co Ltd and Jiangsu Al

20/12/2019 8:30

שיחת ועידה TRACON Pharmaceuticals Inc

TRACON Pharmaceuticals Inc Conference call or earnings call will be held on 20/12/2019
During the earnings conference call’s session, TRACON Pharmaceuticals Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact TRACON Pharmaceuticals Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration, or wet AMD, and fibrotic diseases. We are a leader in the field of endoglin biology and are using our expertise to develop antibodies that bind to the endoglin receptor. Endoglin is essential to angiogenesis, the process of new blood vessel formation, and a key contributor to the development of fibrosis, or tissue scarring. Our lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor, or VEGF, pathway. The VEGF pathway regulates vascular development in the embryo, or vasculogenesis, and angiogenesis.    
קרא עוד שיחת ועידה

TRACON Pharmaceuticals Inc (TCON)

8910 University Center Lane, San Diego California 92122, United States